More Daily Fun with Our Newsletter
By pressing the “Subscribe” button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Service

It’s easy to forget just how much is in your NHS record. Prescriptions, A&E visits, test results, and sensitive notes can all sit in one place, and it’s information most people assume stays tightly controlled.

But in 2026, a major row is building over who gets to handle that data and how much oversight the public really has. It’s exactly the kind of investigative journalism uk readers keep asking for: clear answers on the NHS data contracts shaping how modern healthcare runs.

The focus is the Federated Data Platform (FDP). It’s meant to pull together scattered NHS data so hospitals can plan care better and move faster, but the involvement of a US tech firm has raised fresh questions about control, accountability, and whether the safeguards are as robust as advertised.

For anyone following independent news uk closely, this is one of those untold stories hiding in plain sight: a huge digital infrastructure project, paid for by the public, handling some of the most sensitive information in the country.

The Billion-Pound Data Handover Explained

This story starts with a big procurement decision. In late 2023, the government awarded a £330 million contract to Palantir Technologies to support the rollout of the Federated Data Platform.

Palantir, founded by billionaire Peter Thiel, is known for work linked to the US defence and intelligence world. By March 2026, the FDP rollout is under way across NHS Trusts, with NHS England presenting it as a practical fix for “fragmented” systems that make it harder for services to share information and plan care.

Supporters say the platform is about smoother operations: tracking patient flow, waiting lists, bed capacity, and theatre schedules in one place. The concern is that the software effectively becomes an “operating layer” for highly sensitive NHS data, even if the NHS says the data remains under NHS control and is processed only under instruction.

That gap between ownership and day-to-day influence is where many of the questions sit. Investigative journalism uk scrutiny has focused on transparency: how access is governed, what can be independently audited, and how decisions are made when the system flags risks or prioritises resources.

The cost is also part of the debate. By March 2026, critics say spending has risen as additional modules and custom work are added, arguing the money could otherwise go to staffing or estates. It’s one reason this continues to surface as one of the untold stories in independent news uk coverage: it’s not just technical, it’s political and financial too.

Privacy Red Flags, ‘Mission Creep’, and Your Choices

Privacy campaigners say the biggest worry is not just hacking, but “mission creep” — data collected for healthcare gradually being used for other purposes. Recent reporting, including Sky News coverage in March 2026, has highlighted concern about whether the FDP could make data-sharing with other parts of government easier in practice, even if that is not the stated aim.

Medact has also raised concerns about how effective protections are in the real world. “Pseudonymisation” swaps names for codes, but campaigners argue people can still be re-identified when enough data points are combined, particularly in smaller datasets or unusual case patterns.

Another issue is access. Investigative journalism uk reporting has pointed to correspondence suggesting Palantir staff have, at points, requested access to patient-identifiable data for troubleshooting. The NHS position has been that access is controlled and legally compliant, but the basic question remains: how often is that level of access needed, who approves it, and how is it audited?

Then there’s the question most readers ask: can you opt out? The UK’s National Data Opt-Out is designed to limit use of data for research and planning, but it does not apply to “individual care”. Because the FDP is framed as an operational tool supporting direct care, many experts say the practical impact of opting out may be limited in this context.

The Future of Independent News UK and Your Data

For readers trying to keep track of what’s happening, the hardest part is often the lack of simple, public detail. Who has access day to day, what independent audits show, and how often identifiable data is used for support work can be buried in technical papers or contract language.

That’s where independent news uk reporting matters: taking a big, complex system and sticking to the basics — who controls it, what it does, and what changes for patients in real life.

All of that feeds into the next milestone. The FDP contract is expected to face a major review in early 2027, and the debate is likely to keep growing between now and then. For independent news uk audiences, this remains one of those untold stories worth tracking: decisions made now will shape how NHS data is handled long after the headlines move on.

Advertisement